Lyme Disease Diagnosed by Alternative Methods: A Phenotype Similar to That of Chronic Fatigue Syndrome.

BACKGROUND A subset of patients reporting a diagnosis of Lyme disease can be described as having alternatively diagnosed chronic Lyme syndrome (ADCLS), in which diagnosis is based on laboratory results from a nonreference Lyme specialty laboratory using in-house criteria. Patients with ADCLS report symptoms similar to those reported by patients with chronic fatigue syndrome (CFS). METHODS We performed a case-control study comparing patients with ADCLS and CFS to each other and to both healthy controls and controls with systemic lupus erythematosus (SLE). Subjects completed a history, physical exam, screening laboratory tests, 7 functional scales, reference serology for Lyme disease using Centers for Disease Control and Prevention criteria, reference serology for other tick-associated pathogens, and cytokine expression studies. RESULTS The study enrolled 13 patients with ADCLS (12 of whom were diagnosed by 1 alternative US laboratory), 25 patients with CFS, 25 matched healthy controls, and 11 SLE controls. Baseline clinical data and functional scales indicate significant disability among ADCLS and CFS patients and many important differences between these groups and controls, but no significant differences between each other. No ADCLS patient was confirmed as having positive Lyme serology by reference laboratory testing, and there was no difference in distribution of positive serology for other tick-transmitted pathogens or cytokine expression across the groups. CONCLUSIONS In British Columbia, a setting with low Lyme disease incidence, ADCLS patients have a similar phenotype to that of CFS patients. Disagreement between alternative and reference laboratory Lyme testing results in this setting is most likely explained by false-positive results from the alternative laboratory.

[1]  J. Kilstein,et al.  New diagnostic criteria for fibromyalgia: Here to stay? , 2015, Reumatologia clinica.

[2]  S. Moyano,et al.  New Diagnostic Criteria for Fibromyalgia: Here to Stay? , 2015 .

[3]  M. Gee,et al.  Chronic fatigue syndrome and fibromyalgia in Canada: prevalence and associations with six health status indicators. , 2015, Health promotion and chronic disease prevention in Canada : research, policy and practice.

[4]  M. Pavlicova,et al.  A comparison of lyme disease serologic test results from 4 laboratories in patients with persistent symptoms after antibiotic treatment. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  R. Dattwyler,et al.  Comparison of lyme disease serologic assays and lyme specialty laboratories. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  P. Tang,et al.  1725Surveillance for Borrelia burgdorferi in Ixodes Ticks and Mice in British Columbia , 2014, Open Forum Infectious Diseases.

[7]  Umed Ajani,et al.  Summary of notifiable diseases--United States, 2012. , 2014, MMWR. Morbidity and mortality weekly report.

[8]  J. Gardy,et al.  A metagenomic approach to investigate the microbial causes of myalgic encephalomyelitis/chronic fatigue syndrome: moving beyond XMRV , 2013, Fatigue : biomedicine, health & behavior.

[9]  Le-Xin Wang,et al.  Diagnosis and management of postural orthostatic tachycardia syndrome: A brief review , 2012, Journal of geriatric cardiology : JGC.

[10]  Scott B. Dewell,et al.  Transcriptional profiling of psoriasis using RNA-seq reveals previously unidentified differentially expressed genes , 2011, The Journal of investigative dermatology.

[11]  D. Roth,et al.  How big is the Lyme problem? Using novel methods to estimate the true number of Lyme disease cases in British Columbia residents from 1997 to 2008. , 2011, Vector borne and zoonotic diseases.

[12]  Avrum Spira,et al.  Characterizing the Impact of Smoking and Lung Cancer on the Airway Transcriptome Using RNA-Seq , 2011, Cancer Prevention Research.

[13]  T. Fleisher,et al.  Natural Killer Cell Counts Are Not Different between Patients with Post-Lyme Disease Syndrome and Controls , 2009, Clinical and Vaccine Immunology.

[14]  R. Bratton,et al.  Diagnosis and treatment of Lyme disease. , 2008, Mayo Clinic proceedings.

[15]  J. Halperin,et al.  Erratum: The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America (Clinical Infectious Diseases (2006) 43, (1089-1134)) , 2007 .

[16]  H Artsob,et al.  A critical appraisal of "chronic Lyme disease". , 2007, The New England journal of medicine.

[17]  J. Naschitz,et al.  Orthostatic hypotension: framework of the syndrome , 2007, Postgraduate Medical Journal.

[18]  J. Halperin,et al.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  B. Carruthers Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works , 2006, Journal of Clinical Pathology.

[20]  Ira Schwartz,et al.  Diagnosis of Lyme Borreliosis , 2005, Clinical Microbiology Reviews.

[21]  Suzanne D Vernon,et al.  Cost Effectiveness and Resource Allocation Open Access the Economic Impact of Chronic Fatigue Syndrome , 2022 .

[22]  N. Harris,et al.  Evidence-based guidelines for the management of Lyme disease , 2004, Expert review of anti-infective therapy.

[23]  D. Papanicolaou,et al.  Functional status of persons with chronic fatigue syndrome in the Wichita, Kansas, population , 2003, Health and quality of life outcomes.

[24]  R. Stricker,et al.  Decreased CD57 lymphocyte subset in patients with chronic Lyme disease. , 2001, Immunology letters.

[25]  R. Schondorf,et al.  The importance of orthostatic intolerance in the chronic fatigue syndrome. , 1999, The American journal of the medical sciences.

[26]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[27]  Ian Hickie,et al.  The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.

[28]  D. Burdge,et al.  EXPERIENCE AT A REFERRAL CENTER FOR PATIENTS WITH SUSPECTED LYME DISEASE IN AN AREA OF NONENDEMICITY: FIRST 65 PATIENTS , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  N. Larocca,et al.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. , 1989, Archives of neurology.

[30]  Daniel J Buysse,et al.  The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research , 1989, Psychiatry Research.

[31]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[32]  Bhagat S Malhotra,et al.  Chronic Fatigue Syndrome: A Review , 2011 .

[33]  P. Flor-Henry,et al.  Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols , 2003 .

[34]  I. Hickie,et al.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. , 1994, Annals of internal medicine.

[35]  D. Karnofsky The clinical evaluation of chemotherapeutic agents in cancer , 1949 .

[36]  L. Radloff The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link , 2022 .